Skip to main content
Erschienen in: Journal of Neuro-Oncology 3/2010

01.12.2010 | Laboratory Investigation - Human/Animal Tissue

Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y

verfasst von: Ayhan Bilir, Mine Erguven, Nuray Yazihan, Esin Aktas, Gulperi Oktem, Akin Sabanci

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The aim of this work is to investigate whether clomipramine (CIM) and lithium chloride (LiCl) potentiate the cytotoxicity of vinorelbine (VNR) on SH-SY5Y human neuroblastoma cells in vitro and whether midkine (MK) can be a resistance factor for these treatments. Four groups of experiments were performed for 96 h using both monolayer and spheroid cultures of SH-SY5Y cells: (1) control group, (2) singly applied VNR, CIM, and LiCl, (3) VNR with CIM, and (4) VNR with LiCl. Their effects on monolayer and spheroid cultures were determined by evaluating cell proliferation, bromodeoxyuridine labeling index (BrdU-LI), apoptosis, cyclic adenosine monophosphate (cAMP) and midkine levels, colony-forming efficiency, spheroid size, and ultrastructure. In comparison with the control group, single and combination drug treatments significantly reduced the proliferation index (PI) for 96 h. The most potent reduction of PI was observed with VNR in combination with CIM and LiCl for all time intervals. VNR with CIM and LiCl seemed to be ineffective in reducing BrdU-LI of both monolayer cell and spheroid cultures, spheroid size, and cAMP level. VNR with LiCl increased apoptosis at 24 h, however VNR with CIM increased apoptosis at 96 h. VNR was the most potent drug in inhibiting colony-forming efficiency. The combination of VNR with CIM was the most potent in reducing midkine levels among all groups. Interestingly, the combination of VNR with LiCl led to both nuclear membrane breakdown and disappearance of the cellular membranes inside the spheroids. Both CIM and LiCl seemed to potentiate VNR-induced cytotoxicity, and MK was not a resistance factor for VNR, LiCl, and CIM.
Literatur
1.
Zurück zum Zitat Park JR, Eggert A, Caron H (2008) Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55:97–120CrossRefPubMed Park JR, Eggert A, Caron H (2008) Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55:97–120CrossRefPubMed
2.
Zurück zum Zitat Hu J, Cheung NK (2009) Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. Int J Cancer 124:1700–1706CrossRefPubMed Hu J, Cheung NK (2009) Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. Int J Cancer 124:1700–1706CrossRefPubMed
4.
Zurück zum Zitat Sahebgharani M, Nejati M, Sepehrizadeh Z, Khorramizadeh MR, Bahrololoumi-Shapourabadi M, Hashemi-Bozchlou S et al (2008) Lithium chloride protects PC12 pheochromocytoma cell line from morphine-induced apoptosis. Arch Iran Med 11:639–648PubMed Sahebgharani M, Nejati M, Sepehrizadeh Z, Khorramizadeh MR, Bahrololoumi-Shapourabadi M, Hashemi-Bozchlou S et al (2008) Lithium chloride protects PC12 pheochromocytoma cell line from morphine-induced apoptosis. Arch Iran Med 11:639–648PubMed
5.
Zurück zum Zitat Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y et al (2008) Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10:690–699CrossRefPubMed Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y et al (2008) Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10:690–699CrossRefPubMed
6.
Zurück zum Zitat Serretti A, Drago A, De Ronchi D (2009) Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). Curr Med Chem 16:1917–1948CrossRefPubMed Serretti A, Drago A, De Ronchi D (2009) Lithium pharmacodynamics and pharmacogenetics: focus on inositol mono phosphatase (IMPase), inositol poliphosphatase (IPPase) and glycogen sinthase kinase 3 beta (GSK-3 beta). Curr Med Chem 16:1917–1948CrossRefPubMed
7.
Zurück zum Zitat Wada A (2009) Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110:14–28CrossRefPubMed Wada A (2009) Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110:14–28CrossRefPubMed
8.
Zurück zum Zitat Mann L, Heldman E, Shaltiel G, Belmaker RH, Agam G (2008) Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. Int J Neuropsychopharmacol 11:533–539CrossRefPubMed Mann L, Heldman E, Shaltiel G, Belmaker RH, Agam G (2008) Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. Int J Neuropsychopharmacol 11:533–539CrossRefPubMed
9.
Zurück zum Zitat McTavish D, Benfield P (1990) Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39:136–153CrossRefPubMed McTavish D, Benfield P (1990) Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39:136–153CrossRefPubMed
10.
Zurück zum Zitat Bilir A, Erguven M, Oktem G, Ozdemir A, Uslu A, Aktas E et al (2008) Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma. Int J Oncol 32:829–839PubMed Bilir A, Erguven M, Oktem G, Ozdemir A, Uslu A, Aktas E et al (2008) Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma. Int J Oncol 32:829–839PubMed
11.
Zurück zum Zitat Daley E, Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ et al (2005) Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun 11(328):623–632CrossRef Daley E, Wilkie D, Loesch A, Hargreaves IP, Kendall DA, Pilkington GJ et al (2005) Chlorimipramine: a novel anticancer agent with a mitochondrial target. Biochem Biophys Res Commun 11(328):623–632CrossRef
12.
Zurück zum Zitat Kadomatsu K, Muramatsu T (2004) Midkine and pleiotropin in neural development and cancer. Cancer Lett 204:127–143CrossRefPubMed Kadomatsu K, Muramatsu T (2004) Midkine and pleiotropin in neural development and cancer. Cancer Lett 204:127–143CrossRefPubMed
13.
Zurück zum Zitat Muramatsu T (2002) Midkine and pleiotropin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 132:359–371 Muramatsu T (2002) Midkine and pleiotropin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 132:359–371
14.
Zurück zum Zitat Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T et al (1999) Midkine inhibits caspase dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 73:2084–2092PubMed Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T et al (1999) Midkine inhibits caspase dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 73:2084–2092PubMed
15.
Zurück zum Zitat Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A et al (1995) Differential expression of pleiotropin and midkine in advanced neuroblastomas. Cancer Res 55:1792–1797PubMed Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A et al (1995) Differential expression of pleiotropin and midkine in advanced neuroblastomas. Cancer Res 55:1792–1797PubMed
16.
Zurück zum Zitat Ikematsu S, Nakagawara A, Nakamura Y, Sakuma S, Wakai K, Muramatsu T et al (2003) Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastoma. Br J Cancer 88:1522–1526CrossRefPubMed Ikematsu S, Nakagawara A, Nakamura Y, Sakuma S, Wakai K, Muramatsu T et al (2003) Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastoma. Br J Cancer 88:1522–1526CrossRefPubMed
17.
Zurück zum Zitat Park JR, Eggert A, Caron H (2010) Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 24(1):65–86CrossRefPubMed Park JR, Eggert A, Caron H (2010) Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 24(1):65–86CrossRefPubMed
18.
Zurück zum Zitat Zhou Q, Guo P, Gallo JM (2008) Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res 2014:1540–1549CrossRef Zhou Q, Guo P, Gallo JM (2008) Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res 2014:1540–1549CrossRef
19.
Zurück zum Zitat Conger AD, Ziskin MC (1983) Growth of mammalian multicellular tumor spheroids. Cancer Res 43:556–560PubMed Conger AD, Ziskin MC (1983) Growth of mammalian multicellular tumor spheroids. Cancer Res 43:556–560PubMed
20.
Zurück zum Zitat Kaygisiz Z, Erkasap N, Yazihan N, Sayar K, Ataoglu H, Uyar R et al (2006) Erythropoietin changes contractility, cAMP, and nitrite levels of isolated rat hearts. J Physiol Sci 56:247–251CrossRefPubMed Kaygisiz Z, Erkasap N, Yazihan N, Sayar K, Ataoglu H, Uyar R et al (2006) Erythropoietin changes contractility, cAMP, and nitrite levels of isolated rat hearts. J Physiol Sci 56:247–251CrossRefPubMed
21.
Zurück zum Zitat Yazihan N, Ataoglu H, Akcil E, Yener B, Salman B, Aydin C (2008) Midkine secretion protects Hep3B cells from cadmium induced cellular damage. World J Gastroenterol 14:76–80CrossRefPubMed Yazihan N, Ataoglu H, Akcil E, Yener B, Salman B, Aydin C (2008) Midkine secretion protects Hep3B cells from cadmium induced cellular damage. World J Gastroenterol 14:76–80CrossRefPubMed
22.
Zurück zum Zitat Bilir A, Altinoz MA, Attar E, Erkan M, Aydiner A (2002) Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro. Neoplasma 49:38–42PubMed Bilir A, Altinoz MA, Attar E, Erkan M, Aydiner A (2002) Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro. Neoplasma 49:38–42PubMed
23.
Zurück zum Zitat Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203–216CrossRefPubMed Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203–216CrossRefPubMed
24.
Zurück zum Zitat Guise S, Braguer D, Remacle-Bonnet M, Pommier G, Briand C (1999) Tau protein is involved in the apoptotic process induced by anti-microtubule agents on neuroblastoma cells. Apoptosis 4:47–58CrossRefPubMed Guise S, Braguer D, Remacle-Bonnet M, Pommier G, Briand C (1999) Tau protein is involved in the apoptotic process induced by anti-microtubule agents on neuroblastoma cells. Apoptosis 4:47–58CrossRefPubMed
25.
Zurück zum Zitat Kuttesch JF Jr, Krailo MD, Madden T, Johansen M, Bleyer A, Children’s Oncology Group (2009) Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a children’s oncology group study. Pediatr Blood Cancer 53:590–593CrossRefPubMed Kuttesch JF Jr, Krailo MD, Madden T, Johansen M, Bleyer A, Children’s Oncology Group (2009) Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a children’s oncology group study. Pediatr Blood Cancer 53:590–593CrossRefPubMed
26.
Zurück zum Zitat Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A (2005) Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27:29–42CrossRefPubMed Levkovitz Y, Gil-Ad I, Zeldich E, Dayag M, Weizman A (2005) Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J Mol Neurosci 27:29–42CrossRefPubMed
27.
Zurück zum Zitat Plant KE, Anderson E, Simecek N, Brown R, Forster S, Spinks J et al (2009) The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol 235:124–134CrossRefPubMed Plant KE, Anderson E, Simecek N, Brown R, Forster S, Spinks J et al (2009) The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol 235:124–134CrossRefPubMed
28.
Zurück zum Zitat Allagui MS, Nciri R, Rouhaud MF, Murat JC, El Feki A, Croute F et al (2009) Long-term exposure to low lithium concentrations stimulates proliferation modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res 34:453–462CrossRefPubMed Allagui MS, Nciri R, Rouhaud MF, Murat JC, El Feki A, Croute F et al (2009) Long-term exposure to low lithium concentrations stimulates proliferation modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells. Neurochem Res 34:453–462CrossRefPubMed
29.
Zurück zum Zitat Becchetti A, Whitaker M (1997) Lithium blocks cell cycle transitions in the first cell cycles of sea urchin embryos, an effect rescued by myo-inositol. Development 124:1099–1107PubMed Becchetti A, Whitaker M (1997) Lithium blocks cell cycle transitions in the first cell cycles of sea urchin embryos, an effect rescued by myo-inositol. Development 124:1099–1107PubMed
30.
Zurück zum Zitat Gong D, Pomerening JR, Myers JW, Gustavsson C, Jones JT, Hahn AT et al (2007) Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 17:85–91CrossRefPubMed Gong D, Pomerening JR, Myers JW, Gustavsson C, Jones JT, Hahn AT et al (2007) Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 17:85–91CrossRefPubMed
31.
Zurück zum Zitat Ramalho-Santos J, Schatten G, Moreno RD (2002) Control of membrane fusion during spermiogenesis and the acrosome reaction. Biol Reprod 67:1043–1051CrossRefPubMed Ramalho-Santos J, Schatten G, Moreno RD (2002) Control of membrane fusion during spermiogenesis and the acrosome reaction. Biol Reprod 67:1043–1051CrossRefPubMed
32.
Zurück zum Zitat Darios F, Wasser C, Shakirzyanova A, Giniatullin A, Goodman K, Munoz-Bravo JL et al (2009) Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron 11(62):683–694CrossRef Darios F, Wasser C, Shakirzyanova A, Giniatullin A, Goodman K, Munoz-Bravo JL et al (2009) Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron 11(62):683–694CrossRef
33.
Zurück zum Zitat Takagi A, Watanabe M, Ishii Y, Morita J, Hirokawa Y, Matsuzaki T et al (2007) Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features. Anticancer Res 27:45–53PubMed Takagi A, Watanabe M, Ishii Y, Morita J, Hirokawa Y, Matsuzaki T et al (2007) Three-dimensional cellular spheroid formation provides human prostate tumor cells with tissue-like features. Anticancer Res 27:45–53PubMed
34.
Zurück zum Zitat Laura Cuffi M, Carbonell L, Mármol F, Giménez J, Forn J (2003) Effect of alpha 2-adrenoceptor blockade on lithium action in the rat brain. Brain Res 994:73–80CrossRefPubMed Laura Cuffi M, Carbonell L, Mármol F, Giménez J, Forn J (2003) Effect of alpha 2-adrenoceptor blockade on lithium action in the rat brain. Brain Res 994:73–80CrossRefPubMed
35.
Zurück zum Zitat Srinivas BN, Subhash MN, Vinod KY (2001) Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain. Neurochem Int 38:573–579CrossRefPubMed Srinivas BN, Subhash MN, Vinod KY (2001) Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain. Neurochem Int 38:573–579CrossRefPubMed
36.
Zurück zum Zitat Ibusuki M, Fujimori H, Yamamoto Y, Ota K, Ueda M, Shinriki S et al (2009) Midkine in plasma as a novel breast cancer marker. Cancer Sci 100:1735–1739CrossRefPubMed Ibusuki M, Fujimori H, Yamamoto Y, Ota K, Ueda M, Shinriki S et al (2009) Midkine in plasma as a novel breast cancer marker. Cancer Sci 100:1735–1739CrossRefPubMed
37.
Zurück zum Zitat Xu Y, Qu X, Zhang X, Luo Y, Zhang Y, Luo Y et al (2009) Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Lett 8(279):137–144CrossRef Xu Y, Qu X, Zhang X, Luo Y, Zhang Y, Luo Y et al (2009) Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Lett 8(279):137–144CrossRef
38.
Zurück zum Zitat Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T (2003) Increased serum midkine concentration is a possible tumor marker in patients with superficial esophageal cancer. Oncol Rep 10:411–414PubMed Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T (2003) Increased serum midkine concentration is a possible tumor marker in patients with superficial esophageal cancer. Oncol Rep 10:411–414PubMed
39.
Zurück zum Zitat Obata Y, Kikuchi S, Lin Y, Yagyu K, Muramatsu T, Kumai H (2005) Serum midkine concentrations and gastric cancer. Cancer Sci 96:1792–1797CrossRef Obata Y, Kikuchi S, Lin Y, Yagyu K, Muramatsu T, Kumai H (2005) Serum midkine concentrations and gastric cancer. Cancer Sci 96:1792–1797CrossRef
40.
Zurück zum Zitat Takei Y, Kadomatsu K, Goto T, Muramatsu T (2006) Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer 107:864–873CrossRefPubMed Takei Y, Kadomatsu K, Goto T, Muramatsu T (2006) Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer 107:864–873CrossRefPubMed
41.
Zurück zum Zitat Minegishi T, Kishi H, Tano M, Kameda T, Hirakawa T, Miyamoto K (1999) Control of FSH receptor mRNA expression in rat granulosa cells by 3′, 5′-cyclic adenosine monophosphate, activin, and follistatin. Mol Cell Endocrinol 149:71–77CrossRefPubMed Minegishi T, Kishi H, Tano M, Kameda T, Hirakawa T, Miyamoto K (1999) Control of FSH receptor mRNA expression in rat granulosa cells by 3′, 5′-cyclic adenosine monophosphate, activin, and follistatin. Mol Cell Endocrinol 149:71–77CrossRefPubMed
42.
Zurück zum Zitat de Ridder L, Cornelissen M, de Ridder D (2000) Autologous spheroid culture: a screening tool for human brain tumour invasion. Crit Rev Oncol Hematol 36:107–122CrossRefPubMed de Ridder L, Cornelissen M, de Ridder D (2000) Autologous spheroid culture: a screening tool for human brain tumour invasion. Crit Rev Oncol Hematol 36:107–122CrossRefPubMed
43.
Zurück zum Zitat Livesey KM, Tang D, Zeh HJ, Lotze MT (2009) Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10:1269–1279PubMed Livesey KM, Tang D, Zeh HJ, Lotze MT (2009) Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10:1269–1279PubMed
44.
Zurück zum Zitat Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, Piwocka K, McKenna SL (2009) Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101:1585–1595CrossRef Sullivan-Coyne G, O’Sullivan GC, O’Donovan TR, Piwocka K, McKenna SL (2009) Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101:1585–1595CrossRef
45.
Zurück zum Zitat Wagstaff KM, Jans DA (2009) Nuclear drug delivery to target tumour cells. Eur J Pharmacol 625:174–180CrossRefPubMed Wagstaff KM, Jans DA (2009) Nuclear drug delivery to target tumour cells. Eur J Pharmacol 625:174–180CrossRefPubMed
46.
Zurück zum Zitat Shen YM, Yang XC, Song ML, Qin CH, Yang C, Sun YH (2010) Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells. Hepatobiliary Pancreat Dis Int 9:69–77PubMed Shen YM, Yang XC, Song ML, Qin CH, Yang C, Sun YH (2010) Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells. Hepatobiliary Pancreat Dis Int 9:69–77PubMed
47.
Zurück zum Zitat Dykxhoorn DM (2009) RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat 19:475–491CrossRefPubMed Dykxhoorn DM (2009) RNA interference as an anticancer therapy: a patent perspective. Expert Opin Ther Pat 19:475–491CrossRefPubMed
48.
Zurück zum Zitat Oh YK, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61:850–862CrossRefPubMed Oh YK, Park TG (2009) siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61:850–862CrossRefPubMed
49.
Zurück zum Zitat Papait R, Magrassi L, Rigamonti D, Cattaneo E (2009) Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochem Biophys Res Commun 379:434–439CrossRefPubMed Papait R, Magrassi L, Rigamonti D, Cattaneo E (2009) Temozolomide and carmustine cause large-scale heterochromatin reorganization in glioma cells. Biochem Biophys Res Commun 379:434–439CrossRefPubMed
50.
Zurück zum Zitat Sardi I, Cetica V, Massimino M, Buccoliero AM, Giunti L, Genitori L et al (2009) Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors. Oncol Rep 22:773–779CrossRefPubMed Sardi I, Cetica V, Massimino M, Buccoliero AM, Giunti L, Genitori L et al (2009) Promoter methylation and expression analysis of MGMT in advanced pediatric brain tumors. Oncol Rep 22:773–779CrossRefPubMed
51.
Zurück zum Zitat Bektas M, Johnson SP, Poe WE, Bigner DD, Friedman HS (2009) A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells. Cancer Chemother Pharmacol 64:1053–1058CrossRefPubMed Bektas M, Johnson SP, Poe WE, Bigner DD, Friedman HS (2009) A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells. Cancer Chemother Pharmacol 64:1053–1058CrossRefPubMed
52.
Zurück zum Zitat Lena A, Rechichi M, Salvetti A, Bartoli B, Vecchio D, Scarcelli V et al (2009) Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells. J Transl Med 7:13CrossRefPubMed Lena A, Rechichi M, Salvetti A, Bartoli B, Vecchio D, Scarcelli V et al (2009) Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells. J Transl Med 7:13CrossRefPubMed
54.
Zurück zum Zitat Ralph SJ, Neuzil J (2009) Mitochondria as targets for cancer therapy. Mol Nutr Food Res 53:9–28CrossRefPubMed Ralph SJ, Neuzil J (2009) Mitochondria as targets for cancer therapy. Mol Nutr Food Res 53:9–28CrossRefPubMed
55.
Zurück zum Zitat Dong LF, Freeman R, Liu J, Zobalova R, MarÍn-Hernández A, Stantic M (2009) Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res 15:1593–1600CrossRefPubMed Dong LF, Freeman R, Liu J, Zobalova R, MarÍn-Hernández A, Stantic M (2009) Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res 15:1593–1600CrossRefPubMed
56.
Zurück zum Zitat Rooprai HK, Christidou M, Pilkington GJ (2003) The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 145:683–690CrossRef Rooprai HK, Christidou M, Pilkington GJ (2003) The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas. Acta Neurochir (Wien) 145:683–690CrossRef
Metadaten
Titel
Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y
verfasst von
Ayhan Bilir
Mine Erguven
Nuray Yazihan
Esin Aktas
Gulperi Oktem
Akin Sabanci
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 3/2010
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0209-6

Weitere Artikel der Ausgabe 3/2010

Journal of Neuro-Oncology 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.